StonvexLoading…
StonvexStonvexStonvexCore line items from ACTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $54.24M | $285.23M | $235.10M | $175.66M |
Operating Income | $-8.36M | $6.41M | $19.49M | $25.92M |
Net Income | $-15.74M | $21.68M | $18.26M | $20.99M |
EPS (Diluted) | $-0.16 | $0.22 | $0.19 | $0.22 |
Total Assets | $755.87M | $770.96M | $768.87M | $775.55M |
Total Liabilities | $188.65M | $186.92M | $192.03M | $198.07M |
Cash & Equivalents | $307.51M | $306.72M | $301.78M | $316.72M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 96.59M | 96.48M | 96.46M | 96.44M |